NCT07793851

Brief Summary

The current study is a prospective case series study to evaluate the effect of Fucoidan gel around osseous defects to assess the wound healing and bone regeneration

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jun 2025

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 11, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 11, 2025

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2026

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

August 24, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 31, 2026

Completed
Last Updated

August 31, 2026

Status Verified

August 1, 2026

Enrollment Period

4 months

First QC Date

August 24, 2026

Last Update Submit

August 28, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • wound healing following placement of fucoidan gel

    Landry, Turnbull and Howley wound healing index

    7th day,14th day, 21st day, 1 month, at 3months and 6 months

Secondary Outcomes (1)

  • crestal bone level

    baseline, 3month and 6 month

Study Arms (1)

placement of fucoidan gel in osseous defects

Drug: Fucoidan extracted from F. Vesiculosus placement of fucoidan gel in osseous defects such as intrabony defect, compromised bone support

Eligibility Criteria

Age25 Years - 55 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

All the patients who meet the eligible criteria will undergo Scaling and root planning (SRP) as a part of Phase I therapy. Patients with ≥6mm probing sites will undergo surgical therapy, patients presenting with different osseous defects will be treated with Fucoidan gel. A total of 5 samples will be allotted to different defects

You may qualify if:

  • Systemically healthy patients between 25 to 55 years.
  • Stage II/III and Grade B periodontitis patient.
  • Osseous defects (intra bony defects, compromised bone support and around dental implants)

You may not qualify if:

  • Patients with systemic diseases.
  • Smokers.
  • Patients under anticoagulant therapy.
  • Patients under bisphosphonates.
  • Pregnant and lactating women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Krishnadevaraya college of dental sciences and hospital

Bangalore, Karnataka, 562157, India

Location

Study Officials

  • DR .Prabhuji MLV, MDS

    Krishnadevaraya college of dental sciences and hospital

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 24, 2026

First Posted

August 31, 2026

Study Start

June 11, 2025

Primary Completion

October 11, 2025

Study Completion

June 30, 2026

Last Updated

August 31, 2026

Record last verified: 2026-08

Locations